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Supplemental Experimental Procedures 
Cell lines 
TICs were grown in DMEM/F12 or Kubota medium for all experiments. HEK293T and 
Huh7 cells were cultured in DMEM (Cellgro) with 10% FBS and essential amino acid 
supplements.  
 
Vector 
PPARδ expression and mutant (1-299 aa truncation form) constructs were gifts from Dr. 
Carlo V. Catapano at the Oncology Institute of Southern Switzerland. 
 
Endotoxin measurement 
For endotoxin measurements, blood was collected from inferior vena cava with pyrogen-
free heparin as previously described (Mathurin et al., 2000))  . Extreme care was taken to 
eliminate pyrogen and endotoxin contamination of all surgical instruments and laboratory 
supplies. Blood samples were transferred to appropriate glass tubes made pyrogen-free 
by heating at 180°C for 24 hr. Pyrogen-free water was supplied by the manufacturer. 
Immediately before assay, plasma samples were diluted and heated to 75°C for 10 
minutes to denature endotoxin-binding proteins that can mask endotoxin detection. 
Levels of endotoxin were measured using the Limulus amebocyte lysate pyrogen test 
and a kinetic assay program (Kinetic test, Kinetic-QCL, Santa Clara, CA; BioWhittaker). 
The threshold of endotoxin detection was 0.1 pg/mL.  
 
dsRed imaging analysis 
Tumor progression and metastases (in lungs and spleens) were monitored by whole-
body dsRed bioluminescence imaging (IVIS system, Xenogen) every 8 days over 90 
days, as previously described. Images were captured directly to a microcomputer 
(Xenogen). Imaging at lower magnification that visualizes the entire animal were carried 
out in a light box illuminated by blue light fiber optics (Xenogen, Inc.), and images were 
recorded with a thermoelectrically cooled color CCD camera. 
 
Tumor collection and analysis 
Harvested tumors were measured for the actual volume and weight. The tumor tissues 
were divided for snap-freezing for mRNA and protein analysis of targeted OXPHOS/FAO 
genes and histological fixation with 3% paraformaldehyde followed by sucrose treatment 
for subsequent immune-staining of target gene products. 
 
Gene array analysis of liver 
Systematic gene microarray analyses were performed for dysplastic and normal tumors, 
to identify changes in known or unknown signaling pathways that are tightly associated 
with synergistic induction of liver tumor by Western diet (WD) or alcohol.  For microarray 
analysis, livers isolated from five mice were subjected to RNA isolation, later pooled to 
achieve collection of sufficient amounts of samples for hybridization to the mouse 
microarray (Affymetrix Inc.). The Affymetrix mouse gene chip (Mouse genome 430.2 
array) was used and hybridization and scanning was in the Genome Core Facility 
Children’s Hospital of Los Angeles.  Genes were categorized by related functions for 
assessment of pathophysiological effects of alcohol in liver. 83 gene transcripts of those 
positive showed increased expression using 4.0 fold (balanced differential expression) as 
a cutoff. To identify changes associated with synergism by alcohol or WD, comparative 
analysis was done in the cells isolated from non-Tg mice vs. Tg mice fed WD. Briefly, 
data were background-corrected, normalized by RMA (Robust multi-array average) and 
transformed to median of control samples. Probe level data were summarized to gene 
level. To find differentially expressed genes a t-test (p<0.05) was used and genes were 
further ranked by a fold change. The data have been deposited in GEO of NCBI under 
GSE.  
 
Proteomics 
Proteomic analysis was performed at the Proteomic Exploration Laboratory at California 
Institute of Technology, Pasadena, CA. In brief, the livers were lysed for protein 
extraction and extracted proteins were subjected to one-dimensional SDS gel 
electrophoresis, and stained protein bands were used for in-gel trypsin digestion and MS 
sequencing. 
Chemicals and reagents. Trypsin (modified sequencing grade) was from Promega 
(Madison, WI). Acetonitrile and water (Chromasolv LC-MS quality), iodoacetamide 
(99+%), trifluoroacetic acid (99+%), dithiothreitol (DTT 99%) and glacial acetic acid 
(99%) were supplied by Sigma-Aldrich (St. Louis, MO). 
Isolation and preparation of proteins from mouse liver. Animal handling followed 
AALAC and National Institutes of Health guidelines, and experimental procedures were 
approved by the IACUC. Tissues were homogenized in 1 ml of sodium phosphate buffer 
(pH 7.4) using a Polytron homogenizer at 4°C. Low speed centrifugation (800 rpm) was 
used to remove non-homgenized tissues and debris. Supernatants were re-centrifuged 
and 0.136 ml of 80% sucrose was added to 1 ml of sample. Sodium phosphate buffer 
(pH 7.4 with protease inhibitor) was added, centrifuged for 1 hr at 4°C at 35,000 rpm and 
washed three times with Tris-EDTA (10 mM Tris, 1 mM EDTA) buffer. The pellet fraction 
was subjected to chloroform, methanol and water extraction. The interfacial material 
(proteins) was collected and collected by centrifugation for 15 min at 10,000 rpm. The 
pellet was washed using Tris-EDTA buffer. 
Separation of proteins by 1D PAGE. The protein (10-50 µg in 20 µL of SDS sample 
buffer) were separated using 1D SDS PAGE on a 10% BisTris NuPAGE gel using 
NuPAGE MES SDS running buffer (20X) at a voltage of 120V for the first half hour after 
which the voltage was reduced to 80V The separated proteins on the gel were stained 
using colloidal Coomassie blue (Invitrogen, Carlsbad, CA). 
Protein in-gel digestion. The proteins on the gel were sectioned into 20 pieces, minced 
and destained using 50 mM ammonium bicarbonate buffer (pH 8.0) and acetonitrile. The 
proteins were reduced with 25 µl of 10 mM DTT and alkylated using 25 µl of 55 mM 
iodoacetamide. The proteins were digested using 25 µl of trypsin (6 ng/µl).  
Mass spectrometric analysis. Mass spectrometric analysis was performed by a hybrid 
Orbitrap LC-MS/MS instrument (Thermo Fisher).  
Database searching. MS/MS spectra were searched using Mascot against the 
SwissProt database. Peptide tolerance was 20 ppm and fragment ion tolerance was 0.60 
Da. Carbamidomethylation at cysteines was set as a fixed modification and oxidation of 
methionines was set as a variable modification.  
Parsing using Scaffold. Mascot output files were further curated using Scaffold 3.5.1 
analysis, resulting in a 0.2% protein false discovery rate (FDR) and a 5.3% peptide FDR. 
Further, identification of statistically significantly expressed proteins and heat maps were 
calculated using the R Statistical software package. Amino acid sequences 
corresponding to tryptic peptide masses identified in candidate proteins were subjected 
to the SCAFFOLD analysis software (for confidential protein identification) to rule out 
alternative protein identifications. 	  
Pathway Analysis. Pathway Analysis was performed using Ingenuity Pathway Analysis  
application (Ingenuity Systems, CA). 
 
 
ChIP-seq 
TIC results were compared to CD133(-) control cells for detection of genes with 
increased binding of Nanog. In parallel, isotype control antibody was used as a control. 
Briefly, cells were rinsed twice with PBS and treated with 1% formaldehyde for 20 min at 
room temperature to form DNA-protein crosslinks and sonicated to generate 200-500 bp 
chromatin fragments in size and incubated with anti-NANOG antibodies at 4 °C 
overnight. Protein A/G agarose beads were added to immune complexes at 4 °C.  
Immunoprecipitates were washed three times in wash buffer. ChIP DNA was purified by 
phenol-chloroform extraction and ethanol precipitation. NANOG ChIP for CD133- control 
cells and TICs was carried out as described in an instruction manual of Chromatin 
Immunoprecipitation Assay Kit (Cat#17-295: Millipore Inc., Temecula, CA).  The DNA 
segments obtained by this method were sequenced and further subjected to 
bioinformatics analysis. 
 
Bone marrow transplantation 
Bone marrow transplantation (BMT) was performed as previously described  (Dapito et 
al., 2012; Seki et al., 2007) with modification from traditional protocols as previsouly 
described (Kisseleva et al., 2006; Tsung et al., 2005). Briefly, after Kupffer cells were 
depleted (Van Rooijen and Sanders, 1994), mice were lethally irradiated with 750 cGy 
followed by tail vein intravenous injection of 10 million bone marrow cells collected from 
the femurs/tibias of donor mice.  Donor-derived bone marrow cells reconstitutes only 
30% of Kupffer cells six months after BMT (Kennedy and Abkowitz, 1997). After 12 
weeks following BMT, the efficiency of successful BMT was confirmed by harvesting 
splenocytes and determining LPS responsiveness using IL-6 mRNA induction by 
quantitative real-time PCR, as a readout.  Diethynitrosamine (DEN) or vehicle (PBS) 
were intraperitoneally injected into mice 3 months after BMT. 
 
Isolation of human TICs 
We isolated CD133+/CD49f+ TICs from HCC tissues obtained from alcoholic patients 
with or without HCV infection, as previously described (Chen et al., 2013; Gripon et al., 
2002). Fresh liver cancer tissues were collected from the USC transplant surgery unit in 
collaboration with Dr. Linda Sher. Following harvest, liver cancer specimens were 
immediately digested with collagenase and DNase to obtain cell suspensions, which 
were washed and adjusted to a concentration of 2×107 cells/ml. These cells were 
incubated with antibodies against CD133, CD49f, and CD45 (Becton Dickinson) and 
sorted by FACS to isolate CD133+CD49f+CD45- vs. CD133-CD49f+CD45- populations 
as previously described (Parent et al., 2004).   
 
Bioinformatics analysis of mouse ChIP-seq data 
Approximately, 20 million reads were aligned with the mm9 reference genome using 
Bowtie 2 (version 0.12.7) to generate around 18 million aligned reads with mapping 
quality ≥20, allowing only two mismatches per alignment (Li and Durbin, 2009). Only 
uniquely mapped reads were retained and redundant reads were filtered out. Further, 
each read was extended in the sequencing orientation to a total of 200 bases to infer the 
coverage at each genomic position. The genome was divided into non-overlapping 
windows of 200 bp, and aligned reads were considered to be within a window of the 
midpoint of its estimated fragment. Mid-points in each window were counted, and 
empirical distributions of windows counts were created as described previously (Kim et 
al., 2013). The genomic bins, which contained statistically significant ChIP-Seq 
enrichment, were identified by comparison to a Poisson background model, assuming 
that background reads are spread randomly throughout the genome. In addition, fold- 
enrichment was calculated in CD133 + cells over CD133 – cells. The mapping output 
files were also converted to browser-extensible data (BED) files. For visualization, wiggle 
tracks and TDF file were generated by computing mean read density over 25 bp bins of 
mouse genome with aligned and filtered reads from ChIP-seq data. Wiggle tracks were 
visualized in the IGV (Integrated Genomic Viewer)(Kim et al., 2013) as well as Seqmonk 
(Seqmonk v0.26.9). To assign ChIP-seq enriched regions to genes, a complete set of 
Refseq genes was downloaded from the UCSC genome dataset and, genes with 
enriched regions within 5  kb of their TSSs were called bound. 
 
Gene ontology analysis 
Genes which are differentially associated with NANOG in TICs or control cells were 
functionally analyzed in the context of gene ontology and molecular networks by using 
the Ingenuity pathway software (IPA; http://www.ingenuity.com). Differentially enriched 
genes were categorized into various functional groups (threshold P <0.05) and mapped 
to genetic networks and gene enrichments in specific pathways were calculated. 
For Gene Ontology (GO) analysis, we used the known NANOG motif obtained from 
TRANSFAC to scan our NANOG ChIP-seq data set. In order to gain insight into the 
functions of genes, gene ontology (GO) analysis was performed. We compiled a list of 
GO terms that showed statistically significant over-representation for different classes of 
functions, such as proto-oncogenes, tumor suppression, transcription factors, cell cycle 
and translational regulation, house-keeping genes, developmentally regulated genes, 
immunity and anti-microbial defense genes. Quantitative data were analyzed using 
Partek and Ingenuity software. 
 
Mitochondria labeling and measurement of ROS levels 
To evaluate the status of mitochondria in TICs, the MitoTracker® Mitochondrion-
selective probes for total mitochondrial mass (MitoTracker® Deep Red FM Invitrogen: 
M22426) and for oxidized state mitochondria (MitoSOX™ Red mitochondrial superoxide 
indicator) were added to the media, respectively, and cells subjected to FACS analyses. 
ROS labeling was performed as per the instructions for CellROX® Oxidative stress 
reagent Probes (CellROX® green reagent, Invitrogen C10444). In brief, the cells were 
incubated with staining solution (100 nM) in culture media at 37oC for 30 minutes. After 
staining was complete, cells were washed with PBS and analyzed by fluorescent 
microscopy or flow cytometry. 
 
Fluorescence microscopy 
Cells were fixed in 3.7% formaldehyde for 10 min, blocked in 0.2% BSA for 5 min, and 
incubated with NANOG antibody (1:100; Abcam) and pAMPK antibody (1:100, Cell 
Signaling) in 0.1% Triton-X100 and 1 × PBS, pH 7.4 overnight at 4°C, followed by 
staining with FITC-conjugated rabbit anti-IgG Ab (1:500; Jackson ImmunoResearch) for 
1 h. A LSM 5 Pa laser scanning microscope (Zeiss) was used to visualize mitochondrial 
morphology. 
 
ATP production measurements  
Relative ATP/cell assays were performed in 96-well plates. After cells were treated with 
inhibitors for 4 hr, culture media was removed. Cell Titer-Glo (100 µl: Promega) and 
CyQUANT (Invitrogen) were immediately added to each well. Luminescence and 
fluorescence readings were consecutively measured after room-temperature incubation 
for 10 min. 
 
 
Determination of cis-elements for TLR4-induced Nanog promoter activation 
To characterize the region required for TLR4-induced Nanog transcriptional induction, 
truncated, promoter-luciferase constructs were used to test the functional role of 
predicted and known cis-elements, including E2F1 and NF-κB in its enhancer, and 
others in the promoter.  Six constructs, carrying either a –5421/+50, -4828/+50, -
2342/+50, –900/+50, –332/+50 or –153/+50 Nanog genomic fragment were generated or 
obtained from Dr. Paul Robson at the Genome Institute of Singapore and Dr. Takashi 
Tada in Kyoto University (Kuroda et al., 2005). To generate pGL3(–5421/+50) construct, 
-5421/-4828 PCR fragments was ligated into -4828/+50 construct. Each reporter was co-
transfected with Renilla luciferase plasmid (SV40-Renilla) to normalize reporter activity 
to transfection efficiency of TLR4-transduced Huh7 cells.  Two days after transfection, 
the cells were stimulated with LPS for 24 hr, and the cell lysate was analyzed by a dual 
luciferase assay. 
 
NANOG enhancer and promoter assay following site-directed mutagenesis 
To test the roles of specific sequence elements within these regions, six mutant-
luciferase plasmids were constructed by in vitro mutagenesis using QuikChange™ Site-
Directed Mutagenesis Kit (Stratagene). For example, to examine the function of E2F, 
NF-κB, p53, and IRF-3 elements on LPS-induced Nanog transcriptional activity, 3-bp 
mutations were generated within the corresponding core conserved regions by base 
substitution. To ascertain whether this region serves as a TLR4-responsive enhancer 
through the E2F1 and NF-κB interaction, we used reporter constructs with a 404-bp 
enhancer fragment inserted upstream or downstream of a luciferase reporter driven by 
an Oct4 minimal promoter.  These constructs were obtained from Dr. Ng Huck Hui of the 
Genome Institute of Singapore (Wu et al., 2006). NF-κB and/or E2F binding sites were 
mutated by introducing 3 bp substitutions (Nanog Enh NF-κB and/or E2F mut –Luc) and 
tested for enhancer activity in TLR4-Huh7 cells in the presence or absence of LPS 
stimulation. As a positive control, Nanog enhancer reporter or other control vector was 
co-transfected with E2F and c-MYC expression plasmid into Huh7 cells. The parental 
vector construct without the enhancer insert was used as a negative control. All 
luciferase activities were measured relative to the Renilla luciferase. Basal luciferase 
promoter activity was set arbitrarily to 100% for all comparisons. 
 
Cox6a2 and Acadvl promoter luciferase assay  
The promoter regions of Cox6a2 and Acadvl were inserted into a pGL3 Firefly luciferase 
reporter vector as different truncation forms. Cox6a2 promoter constructs with luciferase 
reporter were gifts of Dr. Moreadith (Wan and Moreadith, 1995). The luciferase assay 
was performed as per vendor instructions (Promega). Briefly, 1 µg of pGL3 luciferase 
plasmid was transfected with Fugene. 100 ng of Renilla plasmid was co-transfected as 
an internal control. Cells were harvested 24 hr after transfection, and cell-free lysates 
were assayed for luciferase activity measured with the dual-luciferase reporter assay kit 
(Promega) using a luminometer. 
 
Lentiviral expression system  
The cDNA for ACADVL was subcloned into the lentiviral vector and dsRed expression 
cassette. Two TLR4 or scrambled shRNAs in the lentiviral vector of pLKO were 
purchased from Sigma-Aldrich. The lentivirus overexpression vectors were purchased 
from Applied Biological Materials and lentivirus shRNA vectors were purchased from 
Sigma-Aldrich. Lentivirus was made by transfecting 2 × 106 HEK293T cells with 10 µg of 
lentiviral vector, 6.5 µg pCMV-ΔR8.2 (packaging vector), and 3.5 µg pCMV-VSV-G 
(envelope vector) using Fugene (Roche). Forty eight hours later, medium was collected, 
filtered, and concentrated using the Lenti-X concentrator (Clontech). Concentrated virus 
was added to TICs, followed by mixing for 2 hr at 37°C in the presence of 8 µg/µl 
polybrene in DMEM/F12 medium.  
 
Reverse transcription and real-time PCR (qPCR) 
Total RNA was extracted from the cells by RNeasy Mini kit (Qiagen). 1 µg of RNA was 
treated with DNase I (Invitrogen) and used for reverse-transcription (Omniscript RT kit, 
Qiagen). Quantitative real-time PCR was performed with Taqman Fast Advanced master 
mix (Invitrogen) using ABI 7900 system (Applied BioSystems). Taqman primers and 
probes for Actin (assay ID: Mm00607939_s1), Nanog (assay ID: Mm02384862_g1), 
Stat3 (assay ID: Mm01219775_m1), Esrrb (assay ID: Mm00442411_m1), Esr2 (assay 
ID: Mm00599821_m1), Pcx (assay ID: Mm00500992_m1), Atp6v1g2 (assay ID: 
Mm01159330_g1), Atp5d (assay ID: Mm00502864_m1), Atp5h (assay ID: 
Mm02392026_g1), Atp8b2 (assay ID: Mm01220121_m1), Acaa2 (assay ID: 
Mm00624282_m1), Cox15 (assay ID: Mm00523096_m1), Cox6a2 (assay ID: 
Mm00438295_g1), Ndufs2 (assay ID: Mm00467603_g1), Ndufv2 (assay ID: 
Mm01239727_m1), Uqcrfs1 (assay ID: Mm00481849_m1), Idh1 (assay ID: 
Mm00516030_m1), Idh2 (assay ID: Mm006124290_m1), Tet1 (assay ID: 
Mm01169087_m1), Tet2 (assay ID: Mm00524395_m1) and Tet3 (assay ID: 
Mm00805756_m1) were obtained from Applied Biosystems.  
 
Immunoblotting 
Cells were lysed in lysis buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 
and 1% Triton-X100) containing 1 × protease inhibitor cocktail (Sigma). Protein (50 
µg/sample) was resolved by 8–15% SDS–PAGE, transferred to nitrocellulose 
membranes, and incubated for 1 hr with 5% milk/TBS-T and overnight with primary Abs 
in 5% BSA. Antibodies used were: TLR4 (Santa Cruz), NANOG (Abcam), TAK1 (Cell 
Signaling), TBK1 (Cell signaling), AMPKs (Cell signaling), E2F1 (Cell signaling), 
pE2F1(Ser337) (Santa Cruz), pE2F1(Ser332) (Thermo Scientific), ACADVL (Santa 
Cruz). ECL Plus (GE Healthcare) was used for chemo-luminescent detection. 
 
XF24 extracellular flux analyzer for measurement of cellular OCR and ECAR 
To measure cellular bioenergetics using extracellular flux, a Seahorse XF96 
Extracellular Flux Analyzer was used following the published protocol (Ahfeldt et al., 
2012; Ferrick et al., 2008). Functional assays of FAO and glycolysis in live cells showed 
that scrambled shRNA-transduced TICs had less glycolytic energetics (an embryonic 
pattern) (Onay-Besikci, 2006) as the baseline while Nanog-silenced TICs had similar 
glycolysis-dependency, but significant activation of FAO. Cells were plated in gelatin-
coated XF 24-well cell culture microplates at 2–7.5 × 104 cells/well (Seahorse 
Bioscience) and incubated in pre-warmed unbuffered DMEM medium (DMEM containing 
2  mM  GlutaMAX, 1  mM sodium pyruvate, 1.85  g  l−1 NaCl and 25  mM glucose) for 1  h. The 
oxygen consumption was measured by the XF24 extracellular flux analyzer (Seahorse 
Biosciences) in unbuffered DMEM assay medium supplemented with 1 mM pyruvate 
and 25 mM glucose after 45 to 60 min equilibration.  
 The characteristic function of mature hepatocytes is 
metabolism/thermogenesis, driven by the catabolic breakdown of lipids. To distinguish 
these tumor cells at a functional level, we analyzed the oxygen consumption rate (OCR) 
and extracellular acidification rate (ECAR) as previously described (Ahfeldt et al.). We 
observed that the basal OCR and ECAR rates were highest in the Nanog-silenced TICs. 
We added compounds that modulated mitochondrial function sequentially and measured 
the effect on OCR and ECAR after the addition of each compound. We first administered 
oligomycin to determine ATP turnover and the degree of proton leakage. At the baseline, 
the Nanog-silenced TICs showed slightly elevated levels of proton leakage when 
compared to unprogrammed cells. After the addition of the electron transport chain 
decoupler (FCCP), we measured the maximal respiratory capacity. Nanog-silenced TICs 
showed significantly higher levels of OCR and ECAR when compared to the 
unprogrammed cells, whereas TICs did not. Finally, we administered antimycin to inhibit 
the flux of electrons through complex III and prevent oxygen consumption by the 
cytochrome c oxidase in the mitochondria as previously described (Ahfeldt et al.). For 
determination of individual ETC complex activities, mitochondrial biogenesis was profiled 
by adding perturbation drugs: 2  µM oligomycin, 0.5  µM FCCP and 5  µM antimycin 
A/rotenone, in succession. OCR for complexes II–IV was measured by first inhibiting 
complex I with rotenone; OCR for complexes III–IV was measured by first inhibiting 
complex II with FCCP; and OCR for complex IV was measured by first inhibiting complex 
III with antimycin. The Etomoxir (ETO, 100  µM)-sensitive component of oxygen 
consumption rate (OCR) represents FAO. Absolute values of OCR were expressed as 
pmol  min−1 per 106 cells and mpH  min−1 per 106 cells. OCR and ECAR were determined 
by plotting the oxygen tension and acidification of the medium in the chamber as a 
function of time and normalized to protein concentration (picomoles per minute per 
milligram), respectively (Ahfeldt et al.). OCR and ECAR were normalized by cell 
numbers in all experiments.  
The ECAR was measured over time at 10  min intervals.  The first three 
measurements were conducted to establish a baseline rate, followed by two 
measurements after the addition of oligomycin, an ATPase inhibitor (I). By uncoupling 
the proton gradient with FCCP, the maximum OCR rates were determined over the next 
two time intervals (II). By addition of glycolysis inhibitor (2-DG) or CPT1 inhibitor (ETO), 
the OCR rates were determined over the next two time intervals (III). Finally, at two time 
points, measurements were conducted after inhibition of the mitochondrial respiratory 
chain with antimycin/rotenon (IV). 
 
Stable-isotope carbon labeling is traced for glutaminolysis analysis 
To test the glutamine utilization, we incubated TICs in 1 mM of [U-13C5, 2,5-15N2]-
glutamine (Cambridge Isotope Laboratory, Cat # CNLM-1275-H-PK) for 4 hr. When [U-
13C5, 2,5-15N2]-glutamine is taken up by cells, it loses the 15N on the 5th carbon and is 
converted to [U-13C5, 2-15N]-glutamate, which loses the 15N on the 2nd carbon and 
becomes [U-13C5]-glutamate after rapid equilibration with TCA cycle intermediate α-
ketoglutarate. When glutamine and glutamate were analyzed by gas chromatography 
mass spectrometry (GC-MS) using electronic impact ionization (EI), their TFA 
derivatives gave rise to C2-C4 (m/z 152) and C2-C5 (m/z 198) fragments (Lee et al., 
1996). Thus, the [U-13C5, 2-15N]-glutamate has a C2-C4 fragment of m/z 156 (M4; 
contains 3x13C and a 15N) and a C2-C5 fragment of m/z 204 (M5; contains 4x13C and a 
15N), which represent the relative abundance of glutamine taken up by the TICs. On the 
other hand, [U-13C5]-glutamate has a C2-C4 fragment of m/z 155 (M3; contains 3x13C) 
and a C2-C5 fragment of m/z 204 (M4; contains 4x13C). When the [U-13C5]-glutamate 
enters TCA cycle metabolism, it will gradually lose the 13C carbon after each cycle and 
generate M2, M1, and M0 C2-C4 fragment and M3, M2, M1, and M0 C2-C5 fragment, 
which represent the TCA cycle activity (Lee et al., 1996).  Vigabatrin (γ–aminobutyric 
acid transaminase: GABA-T) was added in cell culture media and incubated for 20 hr 
then 1 mM [U-13C5, 2-15N]-glutamate was added. The sh-TLR4 or sh-Nanog silencing 
reduced glutamine uptake by the TICs as evident by decreased percentages of M3 and 
M4 glutamate (C2-C4) and M4 and M5 (C2-C5) fragments.  
 
In vivo rescue experiments of OXPHOS genes and inhibition of FAO by 
implantation of TICs into immunocompromised mice 
The effect of restoration of an OXPHOS gene and/or inhibition of FAO for effect on 
tumorigenicity of TICs in a xenograft model was examined. Cryopreserved human TICs 
obtained from liver tumors were tested for tumorigenicity in NOG mice. Prior to 
implantation, these cells were expanded through several passages and infected with the 
lentiviral vector expressing Cox6a2 cDNA and dsRed (as a fluorescence tracing marker 
for in vivo imaging) (MOI 10). Ten days post-lentivirus infection, TICs (1 x 104) were 
subcutaneously injected into 6-8-week-old NOG mice. Tumor growth was monitored and 
palpable tumors were measured by caliper every 4 days for 44 days. 
 
Statistical Considerations 
Log-rank tests and Cox regression was used to determine if differences between groups 
were significant (α = 0.05). The growth of liver tumors was monitored by caliper. The 
normal chow fed mice served as the control to confirm that the alcohol Western diet had 
the intended effect. Data are presented as mean±S.D. A two-tailed t-test was used for 
most comparisons, with p<0.05 considered statistically significant. For the parameters 
measured in the experiment above, two-tailed non-paired Student’s t-test was used for 
comparison between two groups, and p values less than 0.05 were considered 
significant. ANOVA and Fisher’s test was used for comparison of more than two groups. 
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Supplementary	  Table	  1	  (Related	  to	  Fig.	  1).	  Differentially	  expressed	  48	  Signature	  proteins	  in	  three	  groups
SwissProt	  (name) Accession	  no Ensembl	  Gene Ethano+Ns5a	  vs	  Thanol+WT Ethanol+Core	  vs	  Ethanol+WT WD+Core	  vs	  WD+WT
FC Regulation FC Regulation FC Regulation
HMCS2 P54869 ENSMUSG00000027875 0.888888889 DOWN 0.857142857 DOWN 2.222222222 UP
HSP7C P63017 ENSMUSG00000015656 0.833333333 DOWN 4.666666667 UP 0.6 DOWN
DAK Q8VC30 ENSMUSG00000034371 0.666666667 DOWN 2.75 UP 0.533333333 DOWN
METK1 Q91X83 ENSMUSG00000037798 0.666666667 DOWN 10 UP 0.666666667 DOWN
HS90B P11499 ENSMUSG00000023944 0.6 DOWN 2.666666667 UP 0.6 DOWN
AATM P05202 ENSMUSG00000031672 0.833333333 DOWN 3 UP 1.4 UP
TPIS P17751 ENSMUSG00000023456 0.777777778 DOWN 2.333333333 UP 1.333333333 UP
HPPD P49429 ENSMUSG00000029445 0.75 DOWN 2 UP 2 UP
ALDH2 P47738 ENSMUSG00000029455 0.733333333 DOWN 2 UP 1.5625 UP
PRDX5 P99029 ENSMUSG00000024953 0.666666667 DOWN 3 UP 4 UP
ACTB P60710 ENSMUSG00000029580 0.65 DOWN 2.6 UP 1.545454545 UP
MIF P34884 ENSMUSG00000033307 0.571428571 DOWN 1.25 UP 1.25 UP
ETFB Q9DCW4 ENSMUSG00000004610 0.5 DOWN 1.428571429 UP 1.5 UP
UBIQ P62991 ENSMUSG00000008348 0.5 DOWN 3.5 UP 1.375 UP
F16P1 Q9QXD6 ENSMUSG00000069805 10 UP 0.75 DOWN 0.636363636 DOWN
FTHFD Q8R0Y6 ENSMUSG00000030088 2.294117647 UP 0.666666667 DOWN 0.846153846 DOWN
BLVRB Q923D2 ENSMUSG00000040466 1.25 UP 0.666666667 DOWN 0.714285714 DOWN
IREB1 P28271 ENSMUSG00000028405 4 UP 0.5 DOWN 2 UP
PROF1 P62962 ENSMUSG00000018293 4 UP 0.8 DOWN 1.25 UP
CAH3 P16015 ENSMUSG00000027559 1.863636364 UP 0.566666667 DOWN 1.4 UP
FTCD Q91XD4 ENSMUSG00000001155 1.5 UP 0.5 DOWN 1.5 UP
HBB1 P02088 ENSMUSG00000052305 1.341176471 UP 0.698412698 DOWN 1.824561404 UP
CPSM Q8C196 ENSMUSG00000025991 1.333333333 UP 0.954887218 DOWN 1.27388535 UP
GFRP P99025 ENSMUSG00000046814 3 UP 1.5 UP 0.5 DOWN
ASSY P16460 ENSMUSG00000076441 2.083333333 UP 1.125 UP 0.785714286 DOWN
ARLY Q91YI0 ENSMUSG00000025533 2 UP 4.4 UP 0.75 DOWN
INMT P40936 ENSMUSG00000003477 2 UP 2.5 UP 0.75 DOWN
PHS P61458 ENSMUSG00000020098 2 UP 2 UP 0.75 DOWN
ENOA P17182 ENSMUSG00000059040 1.75 UP 2 UP 0.818181818 DOWN
FABPL P12710 ENSMUSG00000054422 1.666666667 UP 1.259259259 UP 0.888888889 DOWN
CBR1 P48758 ENSMUSG00000051483 1.5 UP 6 UP 0.666666667 DOWN
DHB5 P70694 ENSMUSG00000021210 8 UP 3 UP 2 UP
GPX1 P11352 ENSMUSG00000063856 5 UP 5 UP 2.333333333 UP
PARK7 Q99LX0 ENSMUSG00000028964 5 UP 1.333333333 UP 2 UP
PRDX6 O08709 ENSMUSG00000026701 4.5 UP 3.666666667 UP 1.25 UP
CATA P24270 ENSMUSG00000027187 4 UP 3 UP 2 UP
THIM Q8BWT1 ENSMUSG00000036880 3.5 UP 2.5 UP 1.222222222 UP
MAAI Q9WVL0 ENSMUSG00000021033 3.2 UP 1.416666667 UP 1.8 UP
KHK P97328 ENSMUSG00000029162 3 UP 2 UP 1.5 UP
ABHEB Q8VCR7 ENSMUSG00000042073 2 UP 2.5 UP 1.666666667 UP
GLRX1 Q9QUH0 ENSMUSG00000021591 2 UP 2 UP 2 UP
K2C5 Q922U2 ENSMUSG00000061527 2 UP 1.5 UP 3 UP
PEBP1 P70296 ENSMUSG00000032959 2 UP 2 UP 1.333333333 UP
EF1A1 P10126 ENSMUSG00000037742 1.8 UP 1.25 UP 3 UP
ARGI1 Q61176 ENSMUSG00000019987 1.777777778 UP 3 UP 1.833333333 UP
GSTP1 P19157 ENSMUSG00000060803 1.357142857 UP 1.714285714 UP 1.333333333 UP
ACBP P31786 ENSMUSG00000026385 1.333333333 UP 6 UP 1.333333333 UP
G3P P16858 ENSMUSG00000057666 1.25 UP 2 UP 1.375 UP
Supplemental Table 2 (Related to Fig. 1 and 2) Average scores of liver histology in HCV 
Core and/or NS5A Tg mice fed with the ethanol or Western diet (WD) for 12 months. 
Diet  Fatty      Spotty    Inflammation   
liver (0-4+)  necrosis (0-2+)     (0-2+) 
sh-Nanog      LFD+Dextrin  0.3    0   0.1 
Alb-Cre;sh-Nanog    LFD+Dextrin  0.3    0   0.1 
sh-Nanog;NS5A Tg      LFD+Dextrin  0.4    0.1   0.1 
Alb-Cre;sh-Nanog;NS5A Tg  LFD+Dextrin  0.3    0   0.2 
 
sh-Nanog     EtOH+WD  2.4     0.4   0.4 
Alb-Cre;sh-Nanog    EtOH+WD  1.7    0.2   0.8 
sh-Nanog;NS5A Tg      EtOH+WD  3.4    0.9   1.6 
Alb-Cre;sh-Nanog;NS5A Tg  EtOH+WD   1.5    0.3   0.5 
 
Non-Tg          Dextrin   0.3    0.1   0 
Core Tg        Dextrin   0.4    0.1   0.2 
Core/NS5A Tg       Dextrin   0.5    0.3   0.1 
Tlr4-/-       Dextrin   0.2    0   0.4 
Tlr4-/- Core Tg     Dextrin   0.5    0.1   0.1 
Tlr4-/- Core/NS5A Tg    Dextrin   0.4    0.2   0.1 
 
Non-Tg          LFD    0.2    0   0.1 
Core Tg         LFD    0.4    0.1   0.2 
Core/NS5A Tg       LFD    0.5    0.2   0.3 
Tlr4-/- Tg          LFD       0.2    0   0.5 
Tlr4-/- Core Tg     LFD    0.3    0.2   0.3 
Tlr4 -/- Core/NS5A Tg    LFD     0.3    0.1   0.4 
 
Non-Tg          Ethanol   1.0    0.1   0.2 
Core Tg        Ethanol   1.3    0.2   0.9 
Core/Ns5a Tg        Ethanol    1.9    0.4   1.1 
Tlr4-/-       Ethanol   0.4    0.1   0.4 
Tlr4-/- Core Tg     Ethanol   0.8    0.2   0.6 
Tlr4-/- Core/NS5A Tg    Ethanol   1.1    0.2   0.8 
 
Non-Tg          WD    2.2    0.5   0.7 
Core Tg         WD    3.3    0.6   1.1 
Core/NS5A Tg       WD    3.4    0.7   1.3 
Tlr4-/- Tg          WD      1.0    0.1   0.6 
Tlr4-/- Core Tg     WD    1.3    0.2   0.7 
Tlr4 -/- Core/NS5A Tg    WD    1.6    0.3   0.8 
Fatty liver, 2+:25%~50% heaptocytes with fat; 3+:50%~75% with fat; 4+: >75% with fat. 
Submassive necrosis/inflammation, 1+: lesions encompassing less than 1/3 acinus; 2+: 
lesions larger than whole acini. 
LFD: Low fat diet 
HCFD: High-cholesterol high-fat diet 	  	  
 
 	  
